BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 2428248)

  • 1. Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma.
    Huang GS; Chiu LG; Gebb JS; Gunter MJ; Sukumvanich P; Goldberg GL; Einstein MH
    Gynecol Oncol; 2007 Dec; 107(3):513-7. PubMed ID: 17935762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of carcinoembryonic antigen and CA-125 in a patient with multivisceral tuberculosis.
    Mansour M; Linden ER; Colby S; Posner G; Marsh F
    J Natl Med Assoc; 1997 Feb; 89(2):142-3. PubMed ID: 9046768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal trauma releases CA125?
    Redman CW; Jones SR; Luesley DM; Nicholl SE; Kelly K; Buxton EJ; Chan KK; Blackledge GR
    Br J Cancer; 1988 Oct; 58(4):502-4. PubMed ID: 3207605
    [No Abstract]   [Full Text] [Related]  

  • 4. CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and Fallopian tube. II. Immunoradiometric determination in secretions, tissue extracts and serum.
    Crombach G; Scharl A; Würz H
    Arch Gynecol Obstet; 1989; 244(2):113-22. PubMed ID: 2712597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated CA125 serum levels in a patient with tuberculous peritonitis.
    Imai A; Itoh T; Niwa K; Tamaya T
    Arch Gynecol Obstet; 1991; 248(3):157-9. PubMed ID: 2018412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic aspects of endometriosis].
    Kowalski W; Czekanowski R
    Ginekol Pol; 1989 Feb; 60(2):95-100. PubMed ID: 2680791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of CA-125 in patients with endometriosis: a preliminary report.
    Giudice LC; Jacobs A; Pineda J; Bell CE; Lippmann L
    Fertil Steril; 1986 Jun; 45(6):876-8. PubMed ID: 3458595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report.
    Patsner B; Mann WJ
    Cancer; 1988 Oct; 62(7):1355-8. PubMed ID: 3166396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
    Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
    Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA-125 in gynecological malignancies.
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA 125 in gynecologic practice.
    Malkasian GD; Podratz KC; Stanhope CR; Ritts RE; Zurawski VR
    Am J Obstet Gynecol; 1986 Sep; 155(3):515-8. PubMed ID: 2428248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CA 125 tumour-associated antigen: a review of the literature.
    Jacobs I; Bast RC
    Hum Reprod; 1989 Jan; 4(1):1-12. PubMed ID: 2651469
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.